G01N2800/301 - CPC Classification Index

#1

20250376730

2025-12-11

DNA METHYLATION AND GENOTYPE SPECIFIC BIOMARKER FOR PREDICTING POST-TRAUMATIC STRESS DISORDER

#2

20240183845

2024-06-06

BILE ACID METABOLITES FOR DIAGNOSING AND TREATING DEPRESSIVE DISORDERS

#3

20240142471

2024-05-02

TEST FOR MILD COGNITIVE IMPAIRMENT

#4

20230393158

2023-12-07

METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF DEVELOPING A MENTAL AND/OR A BEHAVIOURAL DISORDER

#5

20210404003

2021-12-30

DNA methylation and genotype specific biomarker for predicting post-traumatic stress disorder

#6

20210113144

2021-04-22

METHOD AND APPARATUS FOR PREDICTING POSTTRAUMATIC BEHAVIOR PROBLEM

#7

20200049717

2020-02-13

Application of PDCD4 as a therapeutic target for antidepressants and/or anxiolytics drugs

#8

20190365708

2019-12-05

Vreceptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level

#9

20190125239

2019-05-02

METHOD AND APPARATUS FOR PREDICTING POSTTRAUMATIC BEHAVIOR PROBLEM

#10

20190094240

2019-03-28

BIOMARKERS

#11

20190079082

2019-03-14

Calcium binding protein, spermatid specific 1, as a biomarker for diagnosis or treatment of stress

#12

20190049459

2019-02-14

METHOD FOR IDENTIFYING BIOACTIVE PROTEIN, AND BIOACTIVE PROTEIN OBTAINED BY SAID METHOD

#13

20180208649

2018-07-26

Method for decreasing depression-like behavior with connective tissue growth factor (CTGF) inhibitor

#14

20180120328

2018-05-03

BIOMARKER FOR PSYCHIATRIC AND NEUROLOGICAL DISORDERS

#15

20180042898

2018-02-15

V1B RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF PATIENTS HAVING AN ELEVATED AVP LEVEL AND/OR AN ELEVATED COPEPTIN LEVEL

#16

20180037954

2018-02-08

DNA methylation and genotype specific biomarker for predicting post-traumatic stress disorder

#17

20170343561

2017-11-30

Diagnostic and therapeutic methods and products related to anxiety disorders

#18

20170242036

2017-08-24

PROCESSES AND KITS TO DETECT AND MONITOR FOR DIAGNOSTIC BIOMARKERS FOR POST TRAUMATIC STRESS DISORDER (PTSD) AND TO DIFFERENTIATE BETWEEN SUICIDAL AND NON-SUICIDAL FORM OF THE DISORDER

#19

20170240967

2017-08-24

DISEASE SUSCEPTIBILITY

#20

20170153234

2017-06-01

Method for detecting GABAA receptor autoantibodies

#21

20160305963

2016-10-20

TRANSGENIC ANIMAL MODEL OF MOOD DISORDERS

#22

20160209428

2016-07-21

DIAGNOSTIC AND PREDICTIVE METABOLITE PATTERNS FOR DISORDERS AFFECTING THE BRAIN AND NERVOUS SYSTEM

#23

20160131663

2016-05-12

Biomarker for psychiatric and neurological disorders

#24

20150309050

2015-10-29

Diagnostic and therapeutic methods and products related to anxiety disorders

#25

20150259740

2015-09-17

PROCESSES AND KITS TO DETECT AND MONITOR FOR DIAGNOSTIC BIOMARKERS FOR POST TRAUMATIC STRESS DISORDER (PTSD) AND TO DIFFERENTIATE BETWEEN SUICIDAL AND NON-SUICIDAL FORM OF THE DISORDER

#26

20150099663

2015-04-09

Biomarkers

#27

20150011613

2015-01-08

Methods and compositions for panic disorders

#28

20140301995

2014-10-09

Raising and diagnosing of serotonin level

#29

20140121276

2014-05-01

Method for alleviating fear memory

#30

20120322068

2012-12-20

METHOD FOR IDENTIFYING INCREASED RISK OF ANXIETY DISORDERS

#31

20120291147

2012-11-15

GRAVITATIONAL FLUCTUATION STRESS LOADING METHOD, AIRCRAFT, AIRCRAFT-FLYING METHOD, METHOD FOR PROMOTING SEROTONIN-PRODUCING GENE EXPRESSION, SEROTONIN-PRODUCING METHOD, METHOD FOR STIMULATING CENTRAL NERVOUS SYSTEM, AND EFFICACY-MEASURING METHOD

#32

20120269810

2012-10-25

Methods for treating chronic obstructive pulmonary disease

#33

20120219645

2012-08-30

Chinese Herbal Aqueous Extract Having Anti-Anxiety Activities and Method of In Vitro Evaluating the Same

#34

20120208195

2012-08-16

Disease susceptibility

#35

20100286021

2010-11-11

Methods of Modulating Prokineticin 2 for Treatment of Stress Response and Anxiety-Related Disorders

#36

20100242127

2010-09-23

METHODS TO IDENTIFY MODULATORS OF B-RAF PROTEIN KINASE AND THEIR USE FOR THE TREATMENT OF ANXIETY AND DEPRESSION

#37

20100233818

2010-09-16

Biological Load Indicator and Method of Measuring Biological Load

#38

20100069463

2010-03-18

Method of treating depression

#39

20100029702

2010-02-04

Method For Identification of Compound Having Anti-Anxiety Effect

#40

20090311185

2009-12-17

Peptide having antianxiety activity and screening method therefor

#41

20090305434

2009-12-10

Method of diagnosing neuropsychiatric diseases, eating disorders or metabolic diseases

#42

20090269795

2009-10-29

Mutant alpha4betadelta GABAA receptor and methods of treating anxiety or irritability

#43

20080113915

2008-05-15

SAPAP3 knockout mouse and clinical modeling associated with the SAPAP3 gene

#44

20080038842

2008-02-14

SLITRK1 mutations associated with disorders in the OCD spectrum

#45

20070224636

2007-09-27

Pyrrolo[1,2b]pyridazine compounds and their uses

#46

20070166230

2007-07-19

Ion channel

#47

20070160538

2007-07-12

Method of screening for antianxiety drugs

#48

20070142319

2007-06-21

Anxiolytic treatment by inhibition of a polysialyltransferase

#49

20070111929

2007-05-17

Methods for the treatment of anxiety and for identification of anxiolytic agents

#50

20070038386

2007-02-15

Computer systems and methods for inferring casuality from cellular constituent abundance data

#51

20070037241

2007-02-15

Method for assessing trait anxiety by determining cholinergic status

#52

20060241869

2006-10-26

Computer systems and methods for inferring causality from cellullar constituent abundance data

#53

20060233711

2006-10-19

Method for treating conditions associated with fear memory

#54

20060025582

2006-02-02

Promoter sequences for corticotropin releasing-factor receptor CRF2α and method of identifying agents that alter the activity of the promoter sequences